ESC Premium Access

Promise of epigenetic modulation as a target in atherosclerotic patients.

Topic: Atherosclerosis
Organised by Physicians' Academy for Cardiovascular Education, supported with an educational grant by Resverlogix

Congress Presentation

About the speaker

Professor Erik Stroes

Academic Medical Centre, Amsterdam (Netherlands (The))
39 presentations
0 follower

4 more presentations in this session

Introduction - Managing diabetes & CVD: is epigenetics a new way forward?

Speaker: Professor L. Badimon (Barcelona, ES)

Thumbnail

Managing high risk diabetes patient with cardiovascular disease: what works, and what else can we do?

Speaker: Professor R. Kausik

Thumbnail

Insights from the first trials in epigenetics in human: what is the way forward?

Speaker: Professor S. Nicholls (Melbourne, AU)

Thumbnail

Discussion - Managing diabetes & CVD: is epigenetics a new way forward?

Speaker: Professor R. Kausik

Thumbnail

Access the full session

Managing diabetes & cardiovascular disease (CVD): is epigenetics a new way forward? (EBAC Accredited)

Speakers: Professor E. Stroes, Professor L. Badimon, Professor R. Kausik, Professor S. Nicholls, Professor R. Kausik
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by